Revenue Summary of Abbott India Limited

Abbott India Limited's latest annual revenue in 2023 was 58.48 Billion INR , up 9.35% from previous year.
Abbott India Limited's latest quarterly revenue in 2024 Q1 was 15.57 Billion INR , up 8.27% from previous quarter.
Abbott India Limited reported a annual revenue of 53.48 Billion INR in annual revenue 2022, up 8.93% from previous year.
Abbott India Limited reported a annual revenue of 49.1 Billion INR in annual revenue 2021, up 13.98% from previous year.
Abbott India Limited reported a quarterly revenue of 14.79 Billion INR for 2023 Q1, up 10.51% from previous quarter.
Abbott India Limited reported a quarterly revenue of 58.48 Billion INR for 2023 FY, up 9.35% from previous quarter.

Annual Revenue Chart of Abbott India Limited (2023 - 2004)

Historical Annual Revenue of Abbott India Limited (2023 - 2004)

Year	Revenue	Revenue Growth
2023	58.48 Billion INR	9.35%
2022	53.48 Billion INR	8.93%
2021	49.1 Billion INR	13.98%
2020	43.08 Billion INR	5.3%
2019	40.91 Billion INR	11.31%
2018	36.75 Billion INR	11.36%
2017	33 Billion INR	14.36%
2016	28.85 Billion INR	11.93%
2015	25.78 Billion INR	15.35%
2014	22.35 Billion INR	19.56%
2013	18.69 Billion INR	16.13%
2012	16.09 Billion INR	11.36%
2011	14.45 Billion INR	46.04%
2010	9.89 Billion INR	30.09%
2009	7.6 Billion INR	14.3%
2008	6.65 Billion INR	12.01%
2007	5.94 Billion INR	16.48%
2006	5.1 Billion INR	14.75%
2005	4.44 Billion INR	9.78%
2004	4.05 Billion INR	0.0%

Year	Revenue	Revenue Growth
2024 Q1	15.57 Billion INR	8.27%
2023 Q1	14.79 Billion INR	10.51%
2023 FY	58.48 Billion INR	9.35%
2023 Q4	14.38 Billion INR	0.1%
2023 Q3	14.37 Billion INR	-3.81%
2023 Q2	14.94 Billion INR	1.02%
2022 FY	53.48 Billion INR	8.93%
2022 Q1	13.04 Billion INR	4.68%
2022 Q2	13.79 Billion INR	5.76%
2022 Q3	13.26 Billion INR	-3.84%
2022 Q4	13.38 Billion INR	0.9%
2021 FY	49.1 Billion INR	13.98%
2021 Q4	12.46 Billion INR	1.77%
2021 Q3	12.24 Billion INR	0.19%
2021 Q2	12.22 Billion INR	0.35%
2021 Q1	12.17 Billion INR	11.35%
2020 FY	43.08 Billion INR	5.3%
2020 Q3	10.95 Billion INR	3.84%
2020 Q4	10.93 Billion INR	-0.16%
2020 Q2	10.54 Billion INR	-0.89%
2020 Q1	10.64 Billion INR	10.95%
2019 Q4	9.59 Billion INR	-11.04%
2019 FY	40.91 Billion INR	11.31%
2019 Q1	9.98 Billion INR	10.59%
2019 Q2	10.54 Billion INR	5.6%
2019 Q3	10.78 Billion INR	2.22%
2018 FY	36.75 Billion INR	11.36%
2018 Q1	8.44 Billion INR	7.17%
2018 Q3	9.47 Billion INR	-3.27%
2018 Q2	9.79 Billion INR	15.95%
2018 Q4	9.03 Billion INR	-4.69%
2017 FY	33 Billion INR	14.36%
2017 Q2	9.3 Billion INR	31.85%
2017 Q4	7.88 Billion INR	-10.57%
2017 Q3	8.81 Billion INR	-5.32%
2017 Q1	7.06 Billion INR	-0.42%
2016 Q2	7.21 Billion INR	-1.39%
2016 FY	28.85 Billion INR	11.93%
2016 Q3	7.46 Billion INR	3.45%
2016 Q1	7.31 Billion INR	6.95%
2016 Q4	7.09 Billion INR	-4.95%
2015 Q1	6.23 Billion INR	7.74%
2015 FY	25.78 Billion INR	15.35%
2015 Q3	6.49 Billion INR	2.69%
2015 Q4	6.83 Billion INR	5.23%
2015 Q2	6.32 Billion INR	1.53%
2014 Q3	5.62 Billion INR	-2.62%
2014 FY	22.35 Billion INR	19.56%
2014 Q2	5.77 Billion INR	11.71%
2014 Q1	5.16 Billion INR	-1.2%
2014 Q4	5.78 Billion INR	2.89%
2013 Q2	4.44 Billion INR	3.5%
2013 Q3	4.71 Billion INR	6.09%
2013 Q4	5.23 Billion INR	10.88%
2013 FY	18.69 Billion INR	16.13%
2013 Q1	4.29 Billion INR	5.7%
2012 Q3	4.34 Billion INR	6.87%
2012 Q1	4.02 Billion INR	9.93%
2012 Q2	4.06 Billion INR	0.86%
2012 Q4	4.06 Billion INR	-6.38%
2012 FY	16.09 Billion INR	11.36%
2011 Q3	3.83 Billion INR	-3.33%
2011 Q4	3.66 Billion INR	-4.47%
2011 Q2	3.96 Billion INR	0.0%
2011 FY	14.45 Billion INR	46.04%
2010 FY	9.89 Billion INR	30.09%
2009 FY	7.6 Billion INR	14.3%
2008 FY	6.65 Billion INR	12.01%
2007 FY	5.94 Billion INR	16.48%
2006 FY	5.1 Billion INR	14.75%
2005 FY	4.44 Billion INR	9.78%
2004 FY	4.05 Billion INR	0.0%

Peer Revenue Comparison of Abbott India Limited

Name	Revenue	Revenue Difference
Cipla Limited	257.74 Billion INR	77.307%
Gland Pharma Limited	56.64 Billion INR	-3.251%
GlaxoSmithKline Pharmaceuticals Limited	34.53 Billion INR	-69.352%
Kopran Limited	6.14 Billion INR	-851.674%
Marksans Pharma Limited	21.77 Billion INR	-168.618%
NGL Fine-Chem Limited	3.38 Billion INR	-1626.93%
Pfizer Limited	21.93 Billion INR	-166.687%
Sanofi India Limited	28.51 Billion INR	-105.146%
SMS Pharmaceuticals Limited	7.09 Billion INR	-724.646%
TTK Healthcare Limited	7.52 Billion INR	-676.96%

Global Stocks Search

Abbott India Limited (ABBOTINDIA.NS)

Revenue Summary of Abbott India Limited

Annual Revenue Chart of Abbott India Limited (2023 - 2004)

Historical Annual Revenue of Abbott India Limited (2023 - 2004)

Peer Revenue Comparison of Abbott India Limited